American Beacon Advisors, Inc. Pfizer Inc Transaction History

American Beacon Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 15, 2019	SELL	$38.47 - $43.86 $86,557 - $98,685	-2,250 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$34.47 - $41.81 $6,170 - $7,483	179 Added 8.64%	2,250 $99,000
Q2 2018 Aug 14, 2018	SELL	$32.98 - $35.16 $109,328 - $116,555	-3,315 Reduced 61.55%	2,071 $0
Q4 2017 Feb 12, 2018	BUY	$33.26 - $35.29 $18,991 - $20,150	571 Added 11.86%	5,386 $0
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $89,900 - $99,035	2,900 Added 151.44%	4,815 $0
Q2 2017 Aug 14, 2017	BUY	N/A	1,915	1,915 $64.3 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of American Beacon Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on American Beacon Advisors, Inc. with notifications on news.